Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - C.R. Bard, Inc. (NYSE:BCR)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Reports
Recent Events
Aug  3Dividend payment of $0.21
Aug  2Price hit new 52-week high ($60.25)
Location
730 Central Avenue
Murray Hill, NJ 07974
Phone: (908) 277-8000
Fax: (908) 277-8078
Email: fctc@fcnbd.com
Employees (last reported count): 8,100
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Websites
 ·Home Page
 ·Investor Relations
 ·Employment
 ·Products & Services
 ·Subsidiaries
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Index Membership
 ·S&P 500
Ownership
·Insider and 5%+ Owners: 19%
·Over the last 6 months:
 · 2 insider sells; 32.0K shares
  (0.3% of insider shares)
·Institutional: 72% (89% of float)
(572 institutions)
·Net Inst. Selling: 2.48M shares (+7.21%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
C. R. Bard, Inc. is engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient-care devices. The Company markets its products worldwide to hospitals, individual healthcare professionals, extended-care facilities and alternate-site facilities. Hospitals, physicians and nursing homes purchase approximately 90% of the Company's products, most of which are used once and discarded. Three of Bard's four major product group categories are vascular diagnosis and intervention, urological diagnosis and intervention and oncological diagnosis and intervention. In addition, the Company maintains and grows its fourth major product group, surgical specialties, and also has a product group of other ongoing products.
More from Market Guide: Expanded Business Description

Financial Summary
BCR develops, manufactures and markets health care products, including vascular, urological and oncological diagnosis and intervention products, sold worldwide to hospitals, health care professionals, and extended care and alternate site facilities. For the six months ended 6/01, sales rose 7% to $580.7 million. Net income rose 6% to $68.2 million. Results reflect increased sales of surgery products partially offset by the absence of a $15.4 million gain from the sale of businesses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

William Longfield, 26
Chairman, CEO
$2.2M$929K
Charles Slacik, 46
CFO, Sr. VP
664K--  
Todd Schermerhorn, 40
VP and Treasurer
--  --  
Charles Grom, 53
VP and Controller
--  --  
Nadia Adler, 56
VP, Gen. Counsel and Sec.
--  --  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NYSE:BCRAs of 31-Aug-2001
Price and Volume
52-Week Low
on 19-Oct-2000
$40.188
Recent Price$57.85 
52-Week High
on 2-Aug-2001
$60.25 
Beta0.61 
Daily Volume (3-month avg)719.6K
Daily Volume (10-day avg)418.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+20.1%
52-Week Change
relative to S&P500
+61.1%
Share-Related Items
Market Capitalization$2.97B
Shares Outstanding51.3M
Float41.6M
Dividends & Splits
Annual Dividend (indicated)$0.84 
Dividend Yield1.45%
Last Split: 2 for 1 on 3-Oct-1988
Per-Share Data
Book Value (mrq)$12.87 
Earnings (ttm)$2.15 
Earnings (mrq)$0.68 
Sales (ttm)$22.14 
Cash (mrq)$2.94 
Valuation Ratios
Price/Book (mrq)4.50 
Price/Earnings (ttm)26.86 
Price/Sales (ttm)2.61 
Income Statements
Sales (ttm)$1.14B
EBITDA (ttm)$232.1M
Income available to common (ttm)$110.5M
Profitability
Profit Margin (ttm)9.7%
Operating Margin (ttm)13.9%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)9.98%
Return on Equity (ttm)17.72%
Financial Strength
Current Ratio (mrq)2.60 
Debt/Equity (mrq)0.30 
Total Cash (mrq)$149.8M
Short Interest
As of 8-Aug-2001
Shares Short1.14M
Percent of Float2.7%
Shares Short
(Prior Month)
1.78M
Short Ratio1.40 
Daily Volume814.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   B = billions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.